secwatch.observer — SEC 8-K summary
======================================

Issuer:     BNB PLUS CORP. (BNBX)
CIK:        0000744452
Form:       8-K
Filed at:   2024-05-29T23:59:59+00:00
Accession:  0001104659-24-066098
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Applied DNA Sciences prices $12M public offering of units with warrants subject to stockholder approval
--------------------------------------------------------------------------------

- Gross proceeds of ~$12M from 9,230,769 units at $1.30 per unit (or $1.2999 with pre-funded warrant).
- Each unit includes one share (or pre-funded warrant) plus two Series A and B warrants exercisable at $1.99 after stockholder approval.
- Proceeds to fund therapeutic DNA production services, MDx testing, and general corporate purposes.
- Offering closed May 29, 2024; Craig-Hallum and Laidlaw & Co. acted as placement agents.
- Warrants are not exercisable until stockholder approval obtained; special meeting planned within 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/744452/000110465924066098/0001104659-24-066098-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/744452/000110465924066098/tm2415644d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-066098

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer